Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. - Wikidata - wikimedia - TriplyDB

Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study.

Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study.

http://www.wikidata.org/entity/Q34151453

about

Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure Artificial and bioartificial support systems for liver failure Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure Equipment review: the molecular adsorbents recirculating system (MARS)Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure Survival Benefits With Artificial Liver Support System for Acute-on-Chronic Liver Failure: A Time Series-Based Meta-Analysis Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure Proteomic analysis of polypeptides captured from blood during extracorporeal albumin dialysis in patients with cholestasis and resistant pruritus Effect of an experimental stenosis in the porcine descending thoracic aorta.Life-threatening intoxication with methylene bis(thiocyanate): clinical picture and pitfalls. A case report MARS therapy in critically ill patients with advanced malignancy: a clinical and technical report.Thromboelastography to monitor clotting/bleeding complications in patients treated with the molecular adsorbent recirculating system No sustained impact of intermittent extracorporeal liver support on thrombocyte time course in a randomized controlled albumin dialysis trial.Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure.Personal view: current role of artificial liver support devices.Albumin dialysis in cirrhosis with superimposed acute liver injury: possible impact of albumin dialysis on hospitalization costs.Liver support in fulminant liver failure after hemorrhagic shock.In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD).Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes.Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation: a pilot study.Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation.Oroxylin A accelerates liver regeneration in CCl₄-induced acute liver injury mice Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study.Acute liver failure: a life-threatening disease.Prospects for extracorporeal liver support.The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure.Logistic regression model can reduce unnecessary artificial liver support in hepatitis B virus-associated acute-on-chronic liver failure: decision curve analysis.Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.The European artificial organ scene: present status.Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience.Long-term therapy of a patient with summerskill-walshe-tygstrup syndrome by applying prometheus® liver dialysis: a case report Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure.First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis.Liver support systems: promise and reality.Therapeutic apheresis--state of the art in the year 2005.Continuous molecular adsorbent recirculating system treatment in 69 patients listed for liver transplantation Review article: non-biological liver support in liver failure.Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure.The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure.

P2860

Q21195009-EE9D0C67-1590-46A7-B94D-B33D1F22F7D7 Q24247462-806FA2CA-8AF0-486C-8D9E-7FB4939318C5 Q24676081-6D6B5B75-8D0F-4390-9707-E79E2DBCA841 Q24801094-9424D47E-F770-4688-A3C3-59698FF492AA Q26771851-E5DB8D16-F4D9-46D9-853E-907570F20E5E Q26773433-A4070374-311F-412B-A3D8-D590050F745D Q27499349-6E5DAF96-52E1-4B48-BD45-7B4530045619 Q28742619-6DFC4D7A-4F2E-4D34-B517-271806D87093 Q33208253-2CAB59E5-7D5D-4A13-9CCF-E0AF2BDD5043 Q33239633-7D0FF1D1-0543-4E35-BDFF-35068AFEA6D6 Q33349769-3BDF80FA-94EA-4EA7-9474-957F1A60C43F Q33395093-232ECF93-F540-4189-AA67-985929FC53C0 Q33417539-828CE589-9AF7-40C0-BBCC-4AB3EC4DF285 Q33844163-18EADFBF-2A35-4183-898A-FEDE81050392 Q33995791-68ECF4C0-6B37-438A-941C-A98F4CE37792 Q34227092-F2983027-DDCE-4D3C-9F11-2ACACAA488E6 Q34268155-C160908E-61B0-43FC-8812-D85C8A15889B Q34318152-EE1F98AD-459E-4A23-BF5A-4B095479D14C Q34345919-A222CA80-DFFD-49D0-AD62-A24E3DA972B5 Q34503111-6E3A51BB-20FF-4CC2-8B1E-36A3330F0B9A Q34533308-AC8CD0FE-E92F-4501-8FA7-83C207A18FD5 Q34561715-1F98CBFE-0E13-4253-8F7F-F7FF6032BE50 Q34950079-021D2F09-580E-40B9-914F-0249D73B1F8F Q34999188-DBA69467-1E4B-4A5F-81A1-4C2C136EB08C Q35565411-E85E94D9-2F5C-404E-8BA2-A458224B7CE4 Q35596562-D7B0C1DC-60F7-4E66-8726-8494D47E4CC7 Q35782626-F2491FD1-9D98-4B76-A7E0-1A27ECF6C4AF Q36040654-B2D50B32-01C1-4EA3-B08A-EE1BD6112094 Q36093575-B3DB537F-5B82-49A0-8D42-BB740D2879B6 Q36145893-94042C83-A0FC-4C4E-A634-AC941BDFB88D Q36154078-66698052-0536-4C0C-9C60-876E86832400 Q36206134-85BC7281-64F7-4D90-95C3-2A80D24E2FB6 Q36257253-D2478A03-A088-4412-AE61-EA1182584D27 Q36283332-E0D89132-892A-435A-9F7C-9954BFAF8377 Q36335206-81564E6B-651E-4BEB-993D-F056461B93A4 Q36341821-CEF4FB5E-AEA1-407B-99FE-90DBC48E3EFD Q36357186-BA4C6153-2B13-4051-A5CC-31FBB7AD571F Q36372530-92D7ABA3-5849-4C0B-AFCF-F056CD729BF2 Q36392462-315228B0-D7F3-4911-AE75-CE9BBC740D34 Q36423222-B240EE5B-799D-4845-8721-A65DC9315FB9

P2860

Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study.

http://www.wikidata.org/entity/Q34151453

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Albumin dialysis in cirrhosis ...... prospective, controlled study.

@ast

Albumin dialysis in cirrhosis ...... prospective, controlled study.

@en

Albumin dialysis in cirrhosis ...... prospective, controlled study.

@nl

type

label

Albumin dialysis in cirrhosis ...... prospective, controlled study.

@ast

Albumin dialysis in cirrhosis ...... prospective, controlled study.

@en

Albumin dialysis in cirrhosis ...... prospective, controlled study.

@nl

prefLabel

Albumin dialysis in cirrhosis ...... prospective, controlled study.

@ast

Albumin dialysis in cirrhosis ...... prospective, controlled study.

@en

Albumin dialysis in cirrhosis ...... prospective, controlled study.

@nl

P1433

Q34151453-A5071BE0-2F42-4440-ACFD-5FDEDF408DBC

P1476

Q34151453-BE1F686C-579C-40AD-8B39-3E3B58B716F7

P2093

Q34151453-03566CA7-63E0-454A-9F32-65653E195B5D

Q34151453-10D49533-4F47-487D-A0E5-E3D0EEBB390A

Q34151453-863409FD-336C-490F-AD02-133373C8E7AF

Q34151453-8FE56BE7-8FA4-446C-A796-6918DE3905B6

Q34151453-C310A75A-6F22-4DB5-AFEA-C48E638D1FB5

Q34151453-C789AFDC-69BB-44F1-8B21-1E97704B4835

Q34151453-D4C89904-C41E-489E-AA29-64EAE3BE0EFF

Q34151453-E1DA4854-9C6C-46C6-A518-33ED60744787

Q34151453-F31C07E2-3DF5-4654-A8F6-440BFCD34148

Q34151453-F4CF351C-A6C0-4607-997D-CA4D3558A59C

P304

Q34151453-E894F9E3-C5B3-4853-B2A6-BF3065B334E6

P31

Q34151453-1425933C-A0A5-44DC-8E46-FEE848FBF2CD

P356

Q34151453-5538C02A-21A8-49BE-A9EE-432947729390

P407

Q34151453-1FC78ECC-AEFA-47FA-9C09-1E2C3C97C61C

P433

Q34151453-331114A0-6A39-47C4-8641-114F8154E415

P478

Q34151453-5516102A-00DF-4A8B-B662-208D4FE07D71

P50

Q34151453-19F0391F-5794-4832-8D91-8B470B7B921F

Q34151453-673D00D4-CB4A-49D7-91F5-FE9A90FD3F64

P577

Q34151453-9E101A47-EB94-40C1-B923-3720F0B637B8

P5875

Q34151453-DAB05826-FFFE-437C-B8DB-F5A257A62FAD

P698

Q34151453-D8D15C44-B6C4-4264-9AF9-88713DBE6CEF

P921

Q34151453-A61852FA-35A9-4FEF-9A68-9B0684270903

Q34151453-F5754A50-7CF4-414D-A2AF-05D8C72F6761

P356

JHEP.2002.36130

P1433

P1476

Albumin dialysis in cirrhosis ...... prospective, controlled study.

@en

P2093

Jan Loock

http://www.w3.org/2001/XMLSchema#string

Jan Stange

http://www.w3.org/2001/XMLSchema#string

Massimo Malago

http://www.w3.org/2001/XMLSchema#string

Matthias Loehr

http://www.w3.org/2001/XMLSchema#string

Reinhardt Schmidt

http://www.w3.org/2001/XMLSchema#string

Steffen Mitzner

http://www.w3.org/2001/XMLSchema#string

Stephan Liebe

http://www.w3.org/2001/XMLSchema#string

Thomas Philipp

http://www.w3.org/2001/XMLSchema#string

Ulrich Treichel

http://www.w3.org/2001/XMLSchema#string

Uwe Heemann

http://www.w3.org/2001/XMLSchema#string

P304

949-958

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/JHEP.2002.36130

http://www.w3.org/2001/XMLSchema#string

P407

P433

4 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11125366

http://www.w3.org/2001/XMLSchema#string

P698

12297843

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis